Clonal repertoire diversification of a neutralizing cytomegalovirus glycoprotein B-specific antibody results in variants with diverse anti-viral properties

被引:11
作者
Barrios, Yvelise
Knoer, Susanne
Lantto, Johan
Mach, Michael
Ohlin, Mats
机构
[1] Lund Univ, Dept Immunotechnol, S-22184 Lund, Sweden
[2] Univ Erlangen Nurnberg, Dept CLin & Mol Virol, Erlangen, Germany
关键词
antibody; cytomegalovirus; phage display; repertoire; virus neutralization;
D O I
10.1016/j.molimm.2006.04.024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytomegalovirus induces a chronic infection that in normal individuals is controlled by the immune system. In the case of humoral immunity, epitopes, in particular antigenic domain-1, in glycoprotein B have proven to be important for the induction of virus-neutralizing activity. Such antibodies can exert potent virus-neutralizing activity but can also block neutralizing antibodies from binding. Furthermore, these antibodies differ in their fine recognition of antigenic domain-1 as determined by epitope mapping. By using combinatorial library and phage display technologies we have now isolated a large array of clonally related antibody fragments to understand the origin of this diversity. This procedure allowed us to demonstrate that much of the diversity in functional activity (virus neutralization) and epitope recognition can arise from a single parental molecule through somatic mutation processes. We have thus demonstrated that the clonal diversification of a single antigen-specific clone can account for much of the diversity in antibody anti-viral activity. These findings have implications on the development of a gB-based subunit vaccine, as an effective vaccine preparation need not only to recruit appropriate clones into the immune response but also to evolve them properly so as to maintain an appropriate biological function. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:680 / 690
页数:11
相关论文
共 37 条
[1]   Standard conformations for the canonical structures of immunoglobulins [J].
AlLazikani, B ;
Lesk, AM ;
Chothia, C .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 273 (04) :927-948
[2]   Human cytomegalovirus glycoproteins [J].
Britt, WJ ;
Mach, M .
INTERVIROLOGY, 1996, 39 (5-6) :401-412
[3]   HIV vaccine design and the neutralizing antibody problem [J].
Burton, DR ;
Desrosiers, RC ;
Doms, RW ;
Koff, WC ;
Kwong, PD ;
Moore, JP ;
Nabel, GJ ;
Sodroski, J ;
Wilson, IA ;
Wyatt, RT .
NATURE IMMUNOLOGY, 2004, 5 (03) :233-236
[4]   Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein B antibody transfer in guinea pigs [J].
Chatterjee, A ;
Harrison, CJ ;
Britt, WJ ;
Bewtra, C .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (11) :1547-1553
[5]   Receptors and immune sensors: the complex entry path of human cytomegalovirus [J].
Compton, T .
TRENDS IN CELL BIOLOGY, 2004, 14 (01) :5-8
[6]   THE OUTCOME OF CONGENITAL CYTOMEGALOVIRUS-INFECTION IN RELATION TO MATERNAL ANTIBODY STATUS [J].
FOWLER, KB ;
STAGNO, S ;
PASS, RF ;
BRITT, WJ ;
BOLL, TJ ;
ALFORD, CA .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (10) :663-667
[7]   Locations of herpes simplex virus type 2 glycoprotein B epitopes recognized by human serum immunoglobulin G antibodies [J].
Goade, DE ;
Bell, R ;
Yamada, T ;
Mertz, GJ ;
Jenison, S .
JOURNAL OF VIROLOGY, 1996, 70 (05) :2950-2956
[8]   Antibody evolution from the centre to the periphery: Applied to a human antibody fragment recognising the tumour-associated antigen mucin-1 [J].
Jirholt, P ;
Borrebaeck, CAK ;
Ohlin, M .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 318 (02) :407-416
[9]   Exploiting sequence space:: shuffling in vivo formed complementarity determining regions into a master framework [J].
Jirholt, P ;
Ohlin, M ;
Borrebaeck, CAK ;
Söderlind, E .
GENE, 1998, 215 (02) :471-476
[10]   DISTRIBUTION OF LINEAR ANTIGENIC SITES ON GLYCOPROTEIN GP55 OF HUMAN CYTOMEGALOVIRUS [J].
KNIESS, N ;
MACH, M ;
FAY, J ;
BRITT, WJ .
JOURNAL OF VIROLOGY, 1991, 65 (01) :138-146